Chan; Po Kwok
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chan; Po Kwok.The latest application filed is for "method for screening agent with angiogenic-modulating activities using teleost embryo".
- Chan; Po Kwok - Tseung Kwan O HK
- Chan; Po Kwok - Hong Kong N/A CN
| Patent | Date |
|---|---|
| Method of in vivo screening for cardiac toxic agents using teleost Grant 9,535,057 - Cheng , et al. January 3, 2 | 2017-01-03 |
| Method for screening agent with angiogenic-modulating activities using teleost embryo Grant 9,335,321 - Cheng , et al. May 10, 2 | 2016-05-10 |
| Decorative picture mirror Grant 7,621,651 - Chan , et al. November 24, 2 | 2009-11-24 |
| Method For Screening Agent With Angiogenic-modulating Activities Using Teleost Embryo App 20090232742 - Cheng; Shuk Han ; et al. | 2009-09-17 |
| Method of in Vivo Screening for cardiac Toxic Agents Using Teleost App 20090232739 - Cheng; Shuk Han ; et al. | 2009-09-17 |
| Decorative Picture Mirror App 20080068828 - CHAN; Po Kwok ; et al. | 2008-03-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 